MedPath

Efficacy of the Mckenzie Method in Patients With Chronic Non-Specific Low Back Pain

Not Applicable
Completed
Conditions
Non-specific Chronic Low Back Pain
Interventions
Other: Placebo
Other: McKenzie method
Registration Number
NCT02123394
Lead Sponsor
Universidade Cidade de Sao Paulo
Brief Summary

The purpose of this study is to assess the efficacy of the McKenzie method in patients with chronic non-specific low back.

Detailed Description

One hundred and forty-eight patients will be randomly allocated to two treatment groups: McKenzie method or Placebo (detuned ultrasound and short wave therapy) for 5 weeks (total of 10 sessions of 30 minutes each).

The clinical outcomes will be obtained at the completion of treatment (5 weeks) and at 3, 6, and 12 months after randomization. The data will be collected by a blinded assessor. The statistical analysis will follow the intention-to-treat principles and the between-group differences will be calculated by constructing mixed linear models.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
148
Inclusion Criteria

patients seeking care for chronic non-specific low back pain (defined as pain or discomfort between the costal margins and the inferior gluteal folds, with or without referred symptoms in the lower limbs, for at least 3 months), with a pain intensity of at least 3 points measured by a 0-10 points pain numerical rating scale, aged between 18 and 80 years and able to read in Portuguese.

Exclusion Criteria

patients will be excluded if they have any contraindication to physical exercise or ultrasound or short wave therapy, evidence of nerve root compromise (i.e one or more of motor, reflex or sensation deficit), serious spinal pathology (such as fracture, tumor, inflammatory and infectious diseases), serious cardiovascular and metabolic diseases, previous back surgery and pregnancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboThe patients allocated to the Placebo group will be treated with detuned pulsed ultrasound for 5 minutes and detuned short wave diathermy in pulsed mode for 25 minutes. Patients will receive 10 sessions of treatment over a period of five weeks (two sessions/week).
McKenzie methodMcKenzie methodThe patients of the McKenzie group will be treated according to the principles of the method and the choice of therapeutic intervention will be guided by the physical examination findings and classification. Patients will also receive written instructions from the Treat Your Own Back book and will be asked to perform home exercises based on the principles of McKenzie method. Patients will receive 10 sessions of treatment over a period of five weeks (two sessions/week).
Primary Outcome Measures
NameTimeMethod
Pain Intensity5 weeks after randomization

Pain Intensity will be measured by an 11-point (0-10) Numerical Rating Scale (Pain NRS)

DisabilityFive weeks after randomization

Disability will be measured by the 24-item Roland Morris Disability Questionnaire

Secondary Outcome Measures
NameTimeMethod
KinesiophobiaFive weeks, 3, 6 and 12 months after randomization

Kinesiophobia will be measured by the Tampa Scale of Kinesiophobia by means of 17 questions that deal with pain and intensity of symptoms.

Pain Intensity3, 6 and 12 months after randomization

Pain Intensity will be measured by an 11-point (0-10) Numerical Rating Scale (Pain NRS)

Disability3, 6 and 12 months after randomization

Disability will be measured by the 24-item Roland Morris Disability Questionnaire

FunctionFive weeks, 3, 6 and 12 months after randomization

Disability and function will be measured by an 11-point (0-10) Patient-Specific Functional Scale

Global perceived effectFive weeks, 3, 6 and 12 months after randomization

Global perceived effect will be measured by an 11-point (-5 to +5) Global Perceived Effect Scale

Trial Locations

Locations (1)

Universidade Cidade de Sao Paulo

🇧🇷

Sao Paulo, SP, Brazil

© Copyright 2025. All Rights Reserved by MedPath